Daily Current Affairs 2021 Mucormycosis-Black Fungus Infection in COVID | Daily Current Affairs 2021

Mucormycosis-Black Fungus Infection in COVID

Posted by
Subscribe for News Feed

Mucormycosis, also known as black fungus infection is increasing among the COVID patients.

  • The National COVID Task Force recently issued an advisory against Mucormycosis.
  • This disease is rare but recently this disease has been increasing among COVID patients in Delhi, Gujarat and Maharashtra.

What is Mucormycosis?

  • Mucormycosis sometimes also called zygomycosis is a disease that mainly affects the skin, lungs and brain.
  • It is rare fungal infection.
  • It is caused by a group of molds called Mucoromycetes which are found in soil, leaves, or rotting woods.
  • The fungus can enter the body through breathing, open wounds or cuts.
  • It mainly affects people who are on medication.
  • The lungs or sinuses of the recovering COVID patients get affected after they inhale fungal spores from the air.
  • However, it is not a major threat to those with a healthy immune system.

Symptoms:

  • It causes redness around the eyes, nose.
  • Also, the person suffers from headache, fever, bloody vomits, shortness of breath, altered mental status.
  • Mucormycosis is suspected when a person suffers from sinusitis, local pain on cheek bone, blackish discoloration over bridge of nose, chest pain, thrombosis, plural effusion, necrosis, blurred vision, etc.

How can it be diagnosed?

  • You should see a doctor if you are experiencing the above symptoms post the COVID recovery.
  • A definite diagnosis will be made by the identification of fungi in the patient’s tissue.
  • For this, a doctor may collect a sample of your nasal discharge.

Treatment:

  • Mucormycosis might lead to loss of eyes or upper jaws.
  • Such patients might require a surgery.
  • The treatment of Mucormycosis includes infusion of saline, Amphotericin and other anti-fungal therapies.

Task Force Advisory:

  • Advisory goes on to say that Mucormycosis, if uncared for, may turn fatal.
  • To prevent disease, blood glucose level should be monitored post-Covid discharge
  • The COVID Task Force has recommended to control hyperglycemia after discharge.

Why are COVID patients susceptible to Mucormycosis?

  • The immunity level of a person recovering from COVID-19 is very low.
  • The Mucoromycetes easily affects persons with very low immunity levels.
  • It is especially common among COVID patients who are treated with steroids to reduce inflammation.
  • Inflammation is a condition where a part of the body is swollen, reddened and is often painful due to an infection or reaction to injury.

Subscribe for News Feed

Leave a Reply

Your email address will not be published. Required fields are marked *

*